Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Low-Cysteine diet lower colon cancer risk? new study investigates

NCT ID NCT07086833

Knowledge-focused Sponsor: Purdue University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how eating different amounts of cysteine—a protein building block—affects gut bacteria and inflammation in people at higher risk for colon cancer. Researchers will compare Black and White adults aged 45-75 who have had colon polyps. Participants will follow both a high-cysteine and a low-cysteine diet for three weeks each, and provide blood, stool, and saliva samples to measure inflammation and gut microbes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Low Cysteine Diet and High Cysteine Diet
What this could lead to
If successful, this study could reveal how diet and gut bacteria contribute to colon cancer risk differences between Black and White populations.
What could go wrong
This is a small, early-stage observational study with only 40 participants. It does not test a treatment, so results may not lead to direct health changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 45-75 * Up to date with CRC screening colonoscopy with a high risk of CRC, defined as a history of 3 or more adenomatous polyps (APs) or an AP \>1 cm in the past 5 years * Identify as Black or Non-Hispanic White * If female, no menstrual period for at least six months * Willingness to donate oral wash and stool samples * Willingness to complete 24-hour dietary recalls Exclusion Criteria: * Antibiotic use within the last 6 months * Abnormal gastrointestinal transit * A history of organ transplantation * Use of illicit drugs, combustible tobacco, or dietary supplements * Pre- or probiotics within the last two months * A history of cancer treatment within the past 12 months * CRC or a genetic predisposition to CRC * A baseline body weight \> 450 lbs * Weight gain or loss \> 4 kg 3 months prior to study * Significant food allergies, food preferences or therapeutic or vegetarian diets * Menstrual cycle within the last 6 months * Antibiotics in the last 2 months * Cannot keep a food record for 7 consecutive days during screening after detailed instruction * Significant medical conditions * History of eating disorders * Alcoholism * Individuals under the age of 18

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal adenomatous polyps are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colonic disorder colorectal adenoma colorectal cancer colorectal neoplasm intestinal cancer intestinal disorder neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Purdue Clinical Research Center

    RECRUITING

    West Lafayette, Indiana, 47906, United States

  • University Hospital Clinical Research Center

    NOT_YET_RECRUITING

    Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.